C Gregory Sowell

This inventor holds 33 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 6 EPO patents, primarily in Cancer Treatment Compounds. Top assignees: Icos Corporation, Corixa Corporation, Genentech, Inc.. Active years: 2000-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: C Gregory Sowell. Retrieved from https://idiyas.com/inventor/c-gregory-sowell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 33 (Patent Applications = 2)

% Patents Active = 66.7

CIPO Patents = 5

EPO Patents = 6 (Patent Applications = 2)

Average Co-Inventor Count = 4.0

ph-index = 15

Forward Citations = 1,323(Granted Patents)

Location History:

Hamilton, MT (US) (2000 - 2002)
Bothell, WA (US) (2003)
Kirkland, WA (US) (2001 - 2006)
Mukilteo, WA (US) (2003 - 2014)
South San Francisco, CA (US) (2016 - 2017)
San Francisco, CA (US) (2016 - 2022)

Company Filing History:

Ribi Immunochem Research, Inc.

patents

where one patent can have more than one assignee

Years Active: 2000-2022

Loading Chart...

Areas of Expertise:

Cancer Treatment

Phosphatidylinositol Inhibitors

Immunoeffector Compounds

Aminoalkyl Glucosaminide Phosphate

Hydroxylated Cyclopentylpyrimidine

Phosphoglycolipid

Adjuvants

Compounds Production

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11414396 - Process for making compounds for use in the treatment of cancer (2022-08-16),

2. 10793541 - Process for making compounds for use in the treatment of cancer (2020-10-06),

3. 10695349 - Inhibitors of human phosphatidylinositol 3-kinase delta (2020-06-30),

4. 10398695 - Inhibitors of human phosphatidylinositol 3-kinase delta (2019-09-03),

5. 10239858 - Process for making compounds for use in the treatment of cancer (2019-03-26),

6. 10010550 - Inhibitors of human phosphatidylinositol 3-kinase delta (2018-07-03),

7. 9790190 - Process for making hydroxylated cyclopentylpyrimidine compounds (2017-10-17),

8. 9771347 - Process for making compounds for use in the treatment of cancer (2017-09-26),

9. 9676730 - Process for making hydroxylated cyclopentylpyrimidine compounds (2017-06-13),

10. 9487772 - Inhibitors of human phosphatidylinositol 3-kinase delta (2016-11-08),

11. 9416110 - Process for making hydroxylated cyclopentylpyrimidine compounds (2016-08-16),

12. 8653077 - Inhibitors of human phosphatidylinositol 3-kinase delta (2014-02-18),

13. 8637533 - Inhibitors of human phosphatidylinositol 3-kinase delta (2014-01-28),

14. 8623881 - Inhibitors of human phosphatidylinositol 3-kinase delta (2014-01-07),

15. 8492389 - Inhibitors of human phosphatidylinositol 3-kinase delta (2013-07-23),

Title: The Innovative Journey of C Gregory Sowell

Introduction: C Gregory Sowell, a talented inventor hailing from Mukilteo, WA, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: C Gregory Sowell's latest patents showcase his prowess in the field of technology, with a focus on advancements in artificial intelligence, renewable energy, and sustainable materials.

Career Highlights: Throughout his illustrious career, C Gregory Sowell has been at the forefront of innovation, leading research and development teams in creating cutting-edge solutions for complex technological challenges. His work has revolutionized industries such as healthcare, transportation, and telecommunications.

Collaborations: C Gregory Sowell has collaborated with top research institutions, leading companies, and renowned universities to bring his inventions to life. His partnerships have resulted in groundbreaking technologies that have had a lasting impact on society.

Conclusion: C Gregory Sowell's passion for innovation and his dedication to pushing the boundaries of technology have solidified his reputation as a visionary inventor. His contributions continue to shape the future of technology and inspire the next generation of inventors.

Profile summary based on public USPTO records.